Liberty vs Apex MD
Named sourcing against named inclusions, a hundred dollars apart.
Liberty
Editorial
$199/mo
Liberty prices compounded semaglutide at a flat $199 a month and compounded tirzepatide at a flat $299, and states that both are sourced from a 503B outsourcing facility after a clinician review. A three-month supply brings the semaglutide to about $171 a month. A 503B registers with the FDA and compounds under current good manufacturing practice, which is not the same as approval.
Pick it for: Readers whose first question is where the medication comes from
Apex MD
Editorial
$299/mo
Apex MD prices compounded semaglutide at $299 a month by weekly injection and $349 as a daily oral, with tirzepatide at $399 and $419. The injectable preparation is compounded with NAD, B-12 and L-carnitine in the same vial. Plans are described as month-to-month and the rate is stated as flat at every dose.
Pick it for: Readers whose first question is what the figure already covers
Our verdict
Liberty names its 503B source; Apex MD names what its price contains. Neither leaves the reader guessing, and they chose different things to be clear about.
What actually separates them
Liberty and Apex MD state different things about published price. Everything else they publish, they publish the same way.
Apex MD costs $100 more than Liberty — 50% more for the same molecule. Whether that buys anything is what the rest of this page is for.
Over twelve months that is about $2,388 at Liberty against $3,588 at Apex MD — a difference of $1,200.
| Liberty | Apex MD | |
|---|---|---|
| Published price | $199/mo | $299/mo |
Before you choose either
Ask both sellers what dose the monthly price buys before you compare the two figures. A price is only a price once you know what quantity it is attached to, and a seller that will not answer has told you something. Set both against every published price we hold rather than against each other alone.
Our take is computed from a published rubric that does not read commercial status, and what is known about safety applies to both of them equally.